Andrew Rackear
2011
In 2011, Andrew Rackear earned a total compensation of $684.4K as Vice President and General Counsel at Enzon Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $95,000 |
|---|---|
| Salary | $329,231 |
| Stock Awards | $252,850 |
| Other | $7,350 |
| Total | $684,431 |
Rackear received $329.2K in salary, accounting for 48% of the total pay in 2011.
Rackear also received $95K in non-equity incentive plan, $252.9K in stock awards and $7.4K in other compensation.
Rankings
In 2011, Andrew Rackear's compensation ranked 7,008th out of 10,747 executives tracked by ExecPay. In other words, Rackear earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,008 out of 10,747 | 35th |
Division Manufacturing | 2,554 out of 3,960 | 36th |
Major group Chemicals And Allied Products | 613 out of 1,033 | 41st |
Industry group Drugs | 416 out of 781 | 47th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 157 | 57th |
Source: SEC filing on October 11, 2013.
Rackear's colleagues
We found three more compensation records of executives who worked with Andrew Rackear at Enzon Pharmaceuticals in 2011.